POMALYST® (pomalidomide) is a thalidomide analogue indicated, in combination with dexamethasone, for adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Find a specialty pharmacy.
List of specialty pharmacies.
POMALYST is only available through a select network of specialty pharmacies due to a restricted distribution program called POMALYST REMS®. These specialty pharmacies help to manage the handling and shipping of POMALYST and may provide additional resources.
Access